Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (201-210 of 251) with videos related to

Pageof 26
Sort By:
Surgery, Gynecology & Obstetrics|January 11, 1992
Patterns of recurrence after curative resection of carcinoma of the colon and rectumS Galandiuk, H S Wieand, C G Moertel, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1982
A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinomaM J O'Connell, D S Childs, C G Moertel, et al.
Anesthesiology|January 1, 1987
Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogueH M Marsh, J K Martin, L K Kvols, et al.
Cancer|April 1, 1990
A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancerT E Elliott, C G Moertel, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment GroupC G Moertel, L L Gunderson, J A Mailliard, et al.
Annals of Internal Medicine|July 4, 1998
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology GroupR M Goldberg, T R Fleming, C M Tangen, et al.
Cancer Research|July 1, 1990
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole)M M Ames, C L Loprinzi, J M Collins, et al.
Cancer Treatment Reports|May 1, 1977
Phase II study of pyrazofurin in advanced colorectal carcinomaE T Creagan, J Rubin, C G Moertel, et al.
Cancer|July 1, 1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinomaR H McCreary, C G Moertel, A J Schutt, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Pageof 26

Showing results (201-210 of 251) with videos related to

Sort By:
Pageof 26
Surgery, Gynecology & Obstetrics|January 11, 1992
Patterns of recurrence after curative resection of carcinoma of the colon and rectumS Galandiuk, H S Wieand, C G Moertel, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1982
A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinomaM J O'Connell, D S Childs, C G Moertel, et al.
Anesthesiology|January 1, 1987
Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogueH M Marsh, J K Martin, L K Kvols, et al.
Cancer|April 1, 1990
A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancerT E Elliott, C G Moertel, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment GroupC G Moertel, L L Gunderson, J A Mailliard, et al.
Annals of Internal Medicine|July 4, 1998
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology GroupR M Goldberg, T R Fleming, C M Tangen, et al.
Cancer Research|July 1, 1990
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole)M M Ames, C L Loprinzi, J M Collins, et al.
Cancer Treatment Reports|May 1, 1977
Phase II study of pyrazofurin in advanced colorectal carcinomaE T Creagan, J Rubin, C G Moertel, et al.
Cancer|July 1, 1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinomaR H McCreary, C G Moertel, A J Schutt, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Pageof 26